Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rubin

Showing results (441-450 of 785) with videos related to

Pageof 79
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2021
<i>CYP51A1</i> polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplantTakuto Takahashi, Angela R Smith, Pamala A Jacobson, et al.
Cellular and Molecular Bioengineering|October 18, 2012
Separating Fluid Shear Stress from Acceleration during Vibrations in Vitro: Identification of Mechanical Signals Modulating the Cellular ResponseGunes Uzer, Sarah L Manske, M Ete Chan, et al.
AJR. American Journal of Roentgenology|October 8, 1998
CT colonography with three-dimensional problem solving for detection of colonic polypsA H Dachman, J K Kuniyoshi, C M Boyle, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 22, 2008
Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomesNobuko Taguchi, Evelyn T Rubin, Akiko Hosokawa, et al.
Patient Preference and Adherence|October 2, 2019
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial populationDiana Brixner, Manish Mittal, David T Rubin, et al.
Journal of Crohn'S & Colitis|February 25, 2016
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM TrialDavid T Rubin, Marc Bradette, Libor Gabalec, et al.
Crohn'S & Colitis 360|November 6, 2024
Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative ColitisNoa Krugliak Cleveland, Ninfa Candela, John A Carter, et al.
Journal of Crohn'S & Colitis|May 10, 2017
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysisSudarshan Paramsothy, Ramesh Paramsothy, David T Rubin, et al.
Digestive Diseases and Sciences|February 16, 2010
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient surveyDavid T Rubin, Marla C Dubinsky, Remo Panaccione, et al.
Inflammatory Bowel Diseases|January 29, 2021
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS SurveyDavid T Rubin, Charles Sninsky, Britta Siegmund, et al.
Pageof 79

Showing results (441-450 of 785) with videos related to

Sort By:
Pageof 79
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2021
<i>CYP51A1</i> polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplantTakuto Takahashi, Angela R Smith, Pamala A Jacobson, et al.
Cellular and Molecular Bioengineering|October 18, 2012
Separating Fluid Shear Stress from Acceleration during Vibrations in Vitro: Identification of Mechanical Signals Modulating the Cellular ResponseGunes Uzer, Sarah L Manske, M Ete Chan, et al.
AJR. American Journal of Roentgenology|October 8, 1998
CT colonography with three-dimensional problem solving for detection of colonic polypsA H Dachman, J K Kuniyoshi, C M Boyle, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 22, 2008
Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomesNobuko Taguchi, Evelyn T Rubin, Akiko Hosokawa, et al.
Patient Preference and Adherence|October 2, 2019
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial populationDiana Brixner, Manish Mittal, David T Rubin, et al.
Journal of Crohn'S & Colitis|February 25, 2016
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM TrialDavid T Rubin, Marc Bradette, Libor Gabalec, et al.
Crohn'S & Colitis 360|November 6, 2024
Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative ColitisNoa Krugliak Cleveland, Ninfa Candela, John A Carter, et al.
Journal of Crohn'S & Colitis|May 10, 2017
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysisSudarshan Paramsothy, Ramesh Paramsothy, David T Rubin, et al.
Digestive Diseases and Sciences|February 16, 2010
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient surveyDavid T Rubin, Marla C Dubinsky, Remo Panaccione, et al.
Inflammatory Bowel Diseases|January 29, 2021
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS SurveyDavid T Rubin, Charles Sninsky, Britta Siegmund, et al.
Pageof 79